How many institutions held TYRA - Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share in Q3 2026?

3 institutional investors reported TYRA - Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share for Q3 2026. Use the holders table for investor-level position and value details.

Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (TYRA)

Q: What does CUSIP 90240B106 represent in this 13F holders report?

CUSIP 90240B106 is the security identifier for TYRA - Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 90240B106

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 1,346
Total 13F value: $29,437
Share change: -38
SEC-reported price per share: $21.87
Number of holders: 3
Value change: -$831
Number of buys: 1
Number of sells: 1
Shares outstanding: 69,112,885

Security key

90240B106

Report period

Q3 2026

Institutions

Top holders

TYRA full security history Ownership snapshot Full 13F holder table Tyra Biosciences, Inc. SEC filings Tyra Biosciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 90240B106

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of TYRA - Tyra Biosciences, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

14 Sep 2026

13F 13D/G 3/4/5 Lead comparable stake: 20% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 20%

FMR LLC 14%

Janus Henderson Group Ltd. 7.2%

Farallon Capital Partners, L.P. 6.6%

BIOTECHNOLOGY VALUE FUND L P 6.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G 3/4/5 Company · Director, 10%+ Owner 13F 13D/G 3/4/5	20% from 13D/G	$389,624,083 12,198,625 shares	—	30 Jun 2026
FMR LLC	13D/G 13F Company 13D/G 13F	14%	$296,738,016 7,747,648 shares	+$231,353,566	31 Mar 2026
Janus Henderson Group Ltd.	13D/G JANUS HENDERSON GROUP PLC 13D/G	7.2%	$148,931,747 3,890,589 shares	+$39,592,966	31 Mar 2026
Farallon Capital Partners, L.P.	13D/G Dapice Joshua J. 13D/G	6.6%	$137,073,713 3,580,818 shares	+$22,814,880	31 Mar 2026
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	6.1%	$110,161,101 4,215,886 shares	+$54,565,215	14 Sep 2026
Vi Oncology Scsp Nextech	13D/G Nextech VI Oncology SCSp 13D/G	6%	$115,740,263 3,553,585 shares	$0	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,346

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

167

Q3 2026 holders

Holder diff

-164

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend